CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 647 of 663
Non-Antibody Products
Page 647 of 663
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Voglibose | An α-glucosidase inhibitor (IC50s = 5.6, 0.11, 0.16, and 0.07 µ… | 10 mg | 14179-10 | More Info |
| Voglibose | An α-glucosidase inhibitor (IC50s = 5.6, 0.11, 0.16, and 0.07 µ… | 100 mg | 14179-100 | More Info |
| Voglibose | An α-glucosidase inhibitor (IC50s = 5.6, 0.11, 0.16, and 0.07 µ… | 50 mg | 14179-50 | More Info |
| Voglibose | An α-glucosidase inhibitor (IC50s = 5.6, 0.11, 0.16, and 0.07 µ… | 500 mg | 14179-500 | More Info |
| Volinanserin | A potent and selective antagonist of the serotonin receptor 5-HT2A (Ki = 0… | 1 mg | 15936-1 | More Info |
| Volinanserin | A potent and selective antagonist of the serotonin receptor 5-HT2A (Ki = 0… | 10 mg | 15936-10 | More Info |
| Volinanserin | A potent and selective antagonist of the serotonin receptor 5-HT2A (Ki = 0… | 5 mg | 15936-5 | More Info |
| Vonoprazan (fumarate) | A selective and reversible proton pump inhibitor; inhibits gastric H+/K+ A… | 1 g | 24200-1 | More Info |
| Vonoprazan (fumarate) | A selective and reversible proton pump inhibitor; inhibits gastric H+/K+ A… | 10 g | 24200-10 | More Info |
| Vonoprazan (fumarate) | A selective and reversible proton pump inhibitor; inhibits gastric H+/K+ A… | 5 g | 24200-5 | More Info |
| Vonoprazan (fumarate) | A selective and reversible proton pump inhibitor; inhibits gastric H+/K+ A… | 500 mg | 24200-500 | More Info |
| VO-OHpic (hydrate) | A specific inhibitor of PTEN (IC50 = 35 nM in vitro); increases cellular P… | 1 mg | 10009965-1 | More Info |
| VO-OHpic (hydrate) | A specific inhibitor of PTEN (IC50 = 35 nM in vitro); increases cellular P… | 10 mg | 10009965-10 | More Info |
| VO-OHpic (hydrate) | A specific inhibitor of PTEN (IC50 = 35 nM in vitro); increases cellular P… | 25 mg | 10009965-25 | More Info |
| VO-OHpic (hydrate) | A specific inhibitor of PTEN (IC50 = 35 nM in vitro); increases cellular P… | 5 mg | 10009965-5 | More Info |
| Vorapaxar | A PAR1 antagonist (Ki = 8.1 nM); selective for PAR1 over other PARs, as we… | 1 mg | 23119-1 | More Info |
| Vorapaxar | A PAR1 antagonist (Ki = 8.1 nM); selective for PAR1 over other PARs, as we… | 5 mg | 23119-5 | More Info |
| Vorasidenib | An inhibitor of mutant IDH (IC50s = 31.9 and 31.7 nM for IDH1R132H and IDH… | 1 mg | 28462-1 | More Info |
| Vorasidenib | An inhibitor of mutant IDH (IC50s = 31.9 and 31.7 nM for IDH1R132H and IDH… | 10 mg | 28462-10 | More Info |
| Vorasidenib | An inhibitor of mutant IDH (IC50s = 31.9 and 31.7 nM for IDH1R132H and IDH… | 5 mg | 28462-5 | More Info |
| Voriconazole | A triazole antifungal agent; active against a variety of yeast and fungi (… | 10 mg | 15633-10 | More Info |
| Voriconazole | A triazole antifungal agent; active against a variety of yeast and fungi (… | 25 mg | 15633-25 | More Info |
| Voriconazole | A triazole antifungal agent; active against a variety of yeast and fungi (… | 50 mg | 15633-50 | More Info |
| Voriconazole-d3 | An internal standard for the quantification of voriconazole by GC- or LC-MS | 1 mg | 17803-1 | More Info |
| Voriconazole-d3 | An internal standard for the quantification of voriconazole by GC- or LC-MS | 500 µg | 17803-500 | More Info |
| Voriconazole-d3 N-oxide | An internal standard for the quantification of voriconazole N-oxide by GC-… | 1 mg | 40332-1 | More Info |
| Voriconazole-d3 N-oxide | An internal standard for the quantification of voriconazole N-oxide by GC-… | 100 µg | 40332-100 | More Info |
| Voriconazole-d3 N-oxide | An internal standard for the quantification of voriconazole N-oxide by GC-… | 250 µg | 40332-250 | More Info |
| Voriconazole N-oxide | A major metabolite of voriconazole; formed via oxidation of voriconazole b… | 1 mg | 28047-1 | More Info |
| Voriconazole N-oxide | A major metabolite of voriconazole; formed via oxidation of voriconazole b… | 5 mg | 28047-5 | More Info |
| Vortioxetine | A multimodal serotonergic agent; inhibits 5-HT reuptake (Ki = 1.6 nM); bin… | 10 mg | 30183-10 | More Info |
| Vortioxetine | A multimodal serotonergic agent; inhibits 5-HT reuptake (Ki = 1.6 nM); bin… | 25 mg | 30183-25 | More Info |
| Vortioxetine | A multimodal serotonergic agent; inhibits 5-HT reuptake (Ki = 1.6 nM); bin… | 5 mg | 30183-5 | More Info |
| Vortioxetine | A multimodal serotonergic agent; inhibits 5-HT reuptake (Ki = 1.6 nM); bin… | 50 mg | 30183-50 | More Info |
| Vortioxetine-d8 | An internal standard for the quantification of vortioxetine by GC- or LC-MS | 1 mg | 28163-1 | More Info |
| Vortioxetine (hydrobromide) | A multimodal serotonergic agent; inhibits 5-HT reuptake (Ki = 1.6 nM); bin… | 1 mg | 23694-1 | More Info |
| Vortioxetine (hydrobromide) | A multimodal serotonergic agent; inhibits 5-HT reuptake (Ki = 1.6 nM); bin… | 10 mg | 23694-10 | More Info |
| Vortioxetine (hydrobromide) | A multimodal serotonergic agent; inhibits 5-HT reuptake (Ki = 1.6 nM); bin… | 5 mg | 23694-5 | More Info |
| Voruciclib | A pan-CDK inhibitor (Kis = 0.626-9.1 nM); selective for CDKs over MAK and… | 1 mg | 29085-1 | More Info |
| Voruciclib | A pan-CDK inhibitor (Kis = 0.626-9.1 nM); selective for CDKs over MAK and… | 10 mg | 29085-10 | More Info |
| Voruciclib | A pan-CDK inhibitor (Kis = 0.626-9.1 nM); selective for CDKs over MAK and… | 5 mg | 29085-5 | More Info |
| Vosaroxin | A topoisomerase II inhibitor; induces relaxation of supercoiled DNA (IC50… | 1 mg | 30614-1 | More Info |
| Vosaroxin | A topoisomerase II inhibitor; induces relaxation of supercoiled DNA (IC50… | 10 mg | 30614-10 | More Info |
| Vosaroxin | A topoisomerase II inhibitor; induces relaxation of supercoiled DNA (IC50… | 25 mg | 30614-25 | More Info |
| Vosaroxin | A topoisomerase II inhibitor; induces relaxation of supercoiled DNA (IC50… | 5 mg | 30614-5 | More Info |
| Voxilaprevir | A pan-genotypic HCV NS3 / 4A protease inhibitor; inhibits replication of w… | 1 mg | 33974-1 | More Info |
| Voxilaprevir | A pan-genotypic HCV NS3 / 4A protease inhibitor; inhibits replication of w… | 10 mg | 33974-10 | More Info |
| Voxilaprevir | A pan-genotypic HCV NS3 / 4A protease inhibitor; inhibits replication of w… | 5 mg | 33974-5 | More Info |
| Voxtalisib | A dual inhibitor of PI3K and mTORC (IC50s = 9, 110, 43, 9, 160, and 910 nM… | 10 mg | 30323-10 | More Info |
| Voxtalisib | A dual inhibitor of PI3K and mTORC (IC50s = 9, 110, 43, 9, 160, and 910 nM… | 25 mg | 30323-25 | More Info |
| Voxtalisib | A dual inhibitor of PI3K and mTORC (IC50s = 9, 110, 43, 9, 160, and 910 nM… | 5 mg | 30323-5 | More Info |
| Voxtalisib | A dual inhibitor of PI3K and mTORC (IC50s = 9, 110, 43, 9, 160, and 910 nM… | 50 mg | 30323-50 | More Info |
| VP-14637 | An RSV inhibitor that demonstrates antiviral activity with an EC50 value o… | 1 mg | 17805-1 | More Info |
| VP-14637 | An RSV inhibitor that demonstrates antiviral activity with an EC50 value o… | 10 mg | 17805-10 | More Info |
| VP-14637 | An RSV inhibitor that demonstrates antiviral activity with an EC50 value o… | 5 mg | 17805-5 | More Info |
| VPC 23019 | A competitive antagonist of S1P1 and S1P3 receptors (pKis = 7.86 and 5.93,… | 1 mg | 13240-1 | More Info |
| VPC 23019 | A competitive antagonist of S1P1 and S1P3 receptors (pKis = 7.86 and 5.93,… | 10 mg | 13240-10 | More Info |
| VPC 23019 | A competitive antagonist of S1P1 and S1P3 receptors (pKis = 7.86 and 5.93,… | 5 mg | 13240-5 | More Info |
| VPC 23019 | A competitive antagonist of S1P1 and S1P3 receptors (pKis = 7.86 and 5.93,… | 500 µg | 13240-500 | More Info |
| VPM-p15 (trifluoroacetate salt) | A peptide ADGRG2 agonist; induces cAMP accumulation in HEK293 cells expres… | 1 mg | 37470-1 | More Info |
| VPM-p15 (trifluoroacetate salt) | A peptide ADGRG2 agonist; induces cAMP accumulation in HEK293 cells expres… | 10 mg | 37470-10 | More Info |
| VPM-p15 (trifluoroacetate salt) | A peptide ADGRG2 agonist; induces cAMP accumulation in HEK293 cells expres… | 5 mg | 37470-5 | More Info |
| Vps34-IN1 | A potent and selective inhibitor of Vps34 (IC50 = 25 nM in vitro); dose-de… | 1 mg | 17392-1 | More Info |
| Vps34-IN1 | A potent and selective inhibitor of Vps34 (IC50 = 25 nM in vitro); dose-de… | 10 mg | 17392-10 | More Info |
| Vps34-IN1 | A potent and selective inhibitor of Vps34 (IC50 = 25 nM in vitro); dose-de… | 25 mg | 17392-25 | More Info |
| Vps34-IN1 | A potent and selective inhibitor of Vps34 (IC50 = 25 nM in vitro); dose-de… | 5 mg | 17392-5 | More Info |
| V-PYRRO/NO | V-PYRRO / NO is a NO donor in vivo. Following hepatic metabolism, it spont… | 10 mg | 82160-10 | More Info |
| V-PYRRO/NO | V-PYRRO / NO is a NO donor in vivo. Following hepatic metabolism, it spont… | 100 mg | 82160-100 | More Info |
| V-PYRRO/NO | V-PYRRO / NO is a NO donor in vivo. Following hepatic metabolism, it spont… | 5 mg | 82160-5 | More Info |
| V-PYRRO/NO | V-PYRRO / NO is a NO donor in vivo. Following hepatic metabolism, it spont… | 50 mg | 82160-50 | More Info |
| VR23 | A trypsin-like proteasome inhibitor (IC50 = 1 nM) that deregulates the act… | 1 mg | 19133-1 | More Info |
| VR23 | A trypsin-like proteasome inhibitor (IC50 = 1 nM) that deregulates the act… | 10 mg | 19133-10 | More Info |
| VR23 | A trypsin-like proteasome inhibitor (IC50 = 1 nM) that deregulates the act… | 25 mg | 19133-25 | More Info |
| VR23 | A trypsin-like proteasome inhibitor (IC50 = 1 nM) that deregulates the act… | 5 mg | 19133-5 | More Info |
| VS-5584 | A purine analog that inhibits mTOR (IC50 = 37 nM) and PI3K (IC50s = 16, 68… | 1 mg | 16294-1 | More Info |
| VS-5584 | A purine analog that inhibits mTOR (IC50 = 37 nM) and PI3K (IC50s = 16, 68… | 10 mg | 16294-10 | More Info |
| VS-5584 | A purine analog that inhibits mTOR (IC50 = 37 nM) and PI3K (IC50s = 16, 68… | 5 mg | 16294-5 | More Info |
| VS-5584 analog | A dual inhibitor of PI3Kα and mTOR (IC50s = 17 and 150 nM, respectiv… | 1 mg | 30324-1 | More Info |
| VS-5584 analog | A dual inhibitor of PI3Kα and mTOR (IC50s = 17 and 150 nM, respectiv… | 10 mg | 30324-10 | More Info |
| VS-5584 analog | A dual inhibitor of PI3Kα and mTOR (IC50s = 17 and 150 nM, respectiv… | 25 mg | 30324-25 | More Info |
| VS-5584 analog | A dual inhibitor of PI3Kα and mTOR (IC50s = 17 and 150 nM, respectiv… | 5 mg | 30324-5 | More Info |
| VTP-50469 | An inhibitor of the menin-MLL1 fusion protein interaction (Ki = 0.104 nM);… | 10 mg | 40759-10 | More Info |
| VTP-50469 | An inhibitor of the menin-MLL1 fusion protein interaction (Ki = 0.104 nM);… | 25 mg | 40759-25 | More Info |
| VTP-50469 | An inhibitor of the menin-MLL1 fusion protein interaction (Ki = 0.104 nM);… | 5 mg | 40759-5 | More Info |
| VTP-50469 | An inhibitor of the menin-MLL1 fusion protein interaction (Ki = 0.104 nM);… | 50 mg | 40759-50 | More Info |
| VTP-27999 (trifluoroacetate salt) | A renin inhibitor (IC50 = 0.47 nM for the recombinant human enzyme); selec… | 1 mg | 27689-1 | More Info |
| VTP-27999 (trifluoroacetate salt) | A renin inhibitor (IC50 = 0.47 nM for the recombinant human enzyme); selec… | 10 mg | 27689-10 | More Info |
| VTP-27999 (trifluoroacetate salt) | A renin inhibitor (IC50 = 0.47 nM for the recombinant human enzyme); selec… | 25 mg | 27689-25 | More Info |
| VTP-27999 (trifluoroacetate salt) | A renin inhibitor (IC50 = 0.47 nM for the recombinant human enzyme); selec… | 5 mg | 27689-5 | More Info |
| VTX-27 | A PKCθ inhibitor (Ki = 0.08 nM); selective for PKCθ over PKC&a… | 1 mg | 36938-1 | More Info |
| VTX-27 | A PKCθ inhibitor (Ki = 0.08 nM); selective for PKCθ over PKC&a… | 500 µg | 36938-500 | More Info |
| VU0029251 | A partial antagonist of mGluR5; inhibits calcium mobilization induced by g… | 1 mg | 21987-1 | More Info |
| VU0029251 | A partial antagonist of mGluR5; inhibits calcium mobilization induced by g… | 10 mg | 21987-10 | More Info |
| VU0029251 | A partial antagonist of mGluR5; inhibits calcium mobilization induced by g… | 25 mg | 21987-25 | More Info |
| VU0029251 | A partial antagonist of mGluR5; inhibits calcium mobilization induced by g… | 5 mg | 21987-5 | More Info |
| VU0071063 | A Kir6.2 / SUR1 activator (EC50 = 7 µM) | 1 mg | 21897-1 | More Info |
| VU0071063 | A Kir6.2 / SUR1 activator (EC50 = 7 µM) | 10 mg | 21897-10 | More Info |
| VU0071063 | A Kir6.2 / SUR1 activator (EC50 = 7 µM) | 25 mg | 21897-25 | More Info |
| VU0071063 | A Kir6.2 / SUR1 activator (EC50 = 7 µM) | 5 mg | 21897-5 | More Info |
| VU0119498 | An M1, M3, and M5 muscarinic receptor positive allosteric modulator (EC50s… | 100 mg | 36132-100 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile